India to Mexico: Enoxaparin Export Trade Route

The India to Mexico Enoxaparin corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $2.9M USD. The route is dominated by STANEX DRUGS AND CHEMICALS PRIVATE LIMITED , which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's enoxaparin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $172.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 28.9%, placing it at rank #4 among India's top enoxaparin export destinations globally.

On the import side, key buyers of Indian enoxaparin in Mexico include LABORATORIOS VANQUISH SA DE CV , CARITAS PHARMA S.A DE C.V, CARITAS PHARMA S A DE C V and 1 others. LABORATORIOS VANQUISH SA DE CV is the single largest importer with 6 shipments valued at $1.9M USD.

India's enoxaparin exports to Mexico are driven primarily by a handful of large-scale manufacturers. STANEX DRUGS AND CHEMICALS PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STANEX DRUGS AND CHEMICALS PRIVATE LIMITED , BIOLOGICAL E. LIMITED, BIOLOGICAL E LIMITED — together account for 95% of total trade value on this route. The average shipment value of $172.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as 51000843 - enoxaparin sodium injection usp, 40 mg/0.4 ml and enoxaparin injection ip 80mg/0.8 ml , suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIOS VANQUISH SA DE CV is the largest importer with 6 shipments worth $1.9M USD — representing 64% of all enoxaparin imports from India on this route.